Adenosine A2A receptor agonist (regadenoson) in human lung transplantation

Currently, there are no clinically approved treatments for ischemia-reperfusion injury after lung transplantation. Pre-clinical animal models have demonstrated a promising efficacy of adenosine 2A receptor (A2AR) agonists as a treatment option for reducing ischemia-reperfusion injury. The purpose of...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Journal of heart and lung transplantation 2020-06, Vol.39 (6), p.563-570
Hauptverfasser:	Lau, Christine L., Beller, Jared P., Boys, Joshua A., Zhao, Yunge, Phillips, Jennifer, Cosner, Michael, Conaway, Mark R., Petroni, Gina, Charles, Eric J., Mehaffey, J.H., Mannem, Hannah C., Kron, Irving L., Krupnick, Alexander S., Linden, Joel
Format:	Artikel
Sprache:	eng
Schlagworte:	adenosine Cardiac & Cardiovascular Systems Cardiovascular System & Cardiology clinical trial end stage lung disease IRI Life Sciences & Biomedicine lung transplant pulmonary fibrosis Respiratory System Science & Technology Surgery Transplantation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!